Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies

Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies

US Patent 9387216 · Granted Jul 12, 2016

Estimated economic value: $1,895,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for production of novel galeterone analogs and uses thereof2025
Methods of treating pancreatic cancer2023
13-cis-RAMBA retinamides that degrade MNKs for treating cancer2020
Methods of treating pancreatic cancer2020
Nonsteroidal and steroidal compounds with potent androgen receptor down-regulati2020
Chlorotoxin polypeptides and conjugates and uses thereof2019
C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens, in vitro biological ac2018
Androgen receptor down-regulating agents and uses thereof2018
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapi2017